Woodward, David F.,Carling, William R.,Martos, Jose L.,Wang, Jenny W.,Kangasmetsa, Jussi J.
申请号：
AU2018217252
公开号：
AU2018217252A1
申请日:
2018.08.15
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018217252A120180830.pdf#####ABSTRACT The present invention provides a compound, that is a 1-[(2-{[(alkyl or aryl)methyl]oxy}halo or haloalkyl substituted-phenyl)alkyl]-5-hydrocarby or substituted hydrocarbyl-1 H-pyrazole carboxylic acid or alkylenylcarboxylic acid or a hydrocarbyl or substituted hydrocarbyl sulfonamide of said carboxylic acid or said alkylenylcarboxylic acid, provided however said compound is not a 3carboxylic acid, a sulfonamide thereof, or a 3-methylenylcarboxylic acid. The compound may be represented by the following formula, wherein R1, R2, R3, R4 , R5, R6 , X, W, X and Y are as defined in the specification. The compounds may be administered to treat DP1, FP, EP1, TP and/or EP4 receptor mediated diseases or conditions.
